A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Incyte Corporation
Incyte Corporation
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Cancer Research UK
National Cancer Institute (NCI)
Stanford University
Taproot Health
Sumitomo Pharma America, Inc.
Scripps Health
Celgene
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Shenzhen BinDeBio Ltd.
Fred Hutchinson Cancer Center
Butler Hospital
Celldex Therapeutics
Masonic Cancer Center, University of Minnesota
University of Kansas Medical Center
Wake Forest University Health Sciences
Roswell Park Cancer Institute
Wake Forest University Health Sciences
University of Arizona
Roswell Park Cancer Institute
Hoffmann-La Roche
Novartis
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fox Chase Cancer Center
Stanford University
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, San Francisco
Northside Hospital, Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Liege
Case Comprehensive Cancer Center